How many insider trades does FilingIQ track for HRGN?

FilingIQ tracks 16 Form 4 insider transactions for HRGN (Harvard Apparatus Regenerative Technology, Inc.), covering filings from Aug 18, 2023 onwards. 2 of those were filed in the last 90 days.

Are HRGN insiders net buyers or net sellers?

Across the full Form 4 history for HRGN, 14 transactions (88%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does HRGN insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is HRGN in?

Harvard Apparatus Regenerative Technology, Inc. (HRGN) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $29.48M.

HRGN insider trading

OTC Markets OTCQB Healthcare

Harvard Apparatus Regenerative Technology, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

88% / 0%

Market cap

$29.48M

About Harvard Apparatus Regenerative Technology, Inc.

Harvard Apparatus Regenerative Technology Inc., a clinical-stage biotechnology company, focuses on developing regenerative-medicine treatments for disorders of the gastro-intestinal system and other organs resulting from cancer, trauma, or birth defects. The company's lead product candidate is Cellspan Esophageal Implant for the treatment of severe esophageal disease. It's pipeline includes organ-regeneration technology for the repair or replacement of diseased or damaged organs; and product candidates to treat conditions of the esophagus, including traumatic injury, caustic burns, tissue damage following chemoradiation therapy, birth defects, and reconstruction of the colon and uterus wound repair. The company also sells consumer health products that focuses on personal healthcare, including dietary supplements. Harvard Apparatus Regenerative Technology Inc. was formerly known as Biostage, Inc. and changed its name to Harvard Apparatus Regenerative Technology Inc. in July 2023. The company was founded in 2009 and is headquartered in Holliston, Massachusetts.

Company website: hregen.com

HRGN insider activity at a glance

FilingIQ has scored 16 insider transactions for HRGN since Aug 18, 2023. The most recent filing in our index is dated Jul 21, 2026.

Across the full history, 14 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on HRGN insider trades is 54.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live HRGN trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 983

UNITED THERAPEUTICS Corp

NUVL 195

Nuvalent, Inc.

KYMR 193

Kymera Therapeutics, Inc.

GH 192

Guardant Health, Inc.

Hims & Hers Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for HRGN?: FilingIQ tracks 16 Form 4 insider transactions for HRGN (Harvard Apparatus Regenerative Technology, Inc.), covering filings from Aug 18, 2023 onwards. 2 of those were filed in the last 90 days.
Are HRGN insiders net buyers or net sellers?: Across the full Form 4 history for HRGN, 14 transactions (88%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does HRGN insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is HRGN in?: Harvard Apparatus Regenerative Technology, Inc. (HRGN) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $29.48M.

Methodology & sources

Every HRGN insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.